Delivery Order SPE2DB22D3501-SPE2DB23FWS79
Award Date 8/3/23
Potential Completion Date 8/4/23
Potential Value $34
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $34,040 delivery order to Amerisourcebergen Drug Corporation for 4562056055 Novolog 100 unit/ml FlexPen 3ml insulin delivery devices. As the prime contractor, Amerisourcebergen will deliver the insulin pens to a facility in Conshohocken, Pennsylvania by September 6, 2023 under a firm fixed price contract structure. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to support all military services and...
- The Defense Logistics Agency awarded a $1,781.88 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562331403 Novolog 100 unit/ml FlexPen 3ml insulin delivery devices. The delivery order was issued under an existing prime vendor contract vehicle and calls for the delivery of the specified insulin pens to a facility located in Conshohocken, Pennsylvania by September 28, 2023. As a leading provider of medical supplies and pharmaceuticals to the Department of...
- The Defense Logistics Agency awarded a $408 delivery order to Amerisourcebergen Drug Corporation for 4561378006 Novolog 100 unit/ml Flexpen 3ml insulin delivery devices. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning June 29-30, 2023. As a leading provider of pharmaceuticals and medical supplies, Amerisourcebergen will deliver the contracted insulin pens in support of the Defense Logistics Agency's mission...
- The Defense Logistics Agency awarded a $382,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 unit/ml Novolog Flexpen 3ml insulin delivery devices. As a major distributor of pharmaceutical and medical supplies for the Department of Defense, Amerisourcebergen will deliver the insulin pens from its Conshohocken, Pennsylvania distribution center to support DLA's medical logistics requirements. The single day order period from July 13-14, 2023...
- The Defense Logistics Agency awarded a delivery order valued at $8,844.26 to AmerisourceBergen Drug Corp for the supply of Novolog 100 Unit/ML FlexPen 3ML insulin pens. This is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, awarded on August 21, 2025, without a set-aside designation. The award will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $408 delivery order to Amerisourcebergen Drug Corporation for 4562145935 Novolog Penfill insulin delivery devices. As the prime contractor, Amerisourcebergen will supply approximately 100 units of the 3mL pre-filled insulin pens to support DLA's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania under a firm fixed-price structure from September 12-13, 2023. As a leading provider of pharmaceuticals...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,464.90 to AmerisourceBergen Drug Corp for the supply of Novolog 100 Unit/ML FlexPen 3ML insulin pens. This competitively awarded, firm fixed-price delivery order was issued on November 26, 2025, with an ultimate completion date of November 28, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery...
- The Defense Logistics Agency awarded a $272 delivery order to Amerisourcebergen Drug Corporation for 4561937361 Novolog 100 unit/ml FlexPen 3ml insulin devices. As the prime contractor, Amerisourcebergen will deliver the medical supplies to a customer located in Conshohocken, Pennsylvania by August 25, 2023. The firm fixed price contract was awarded under an existing DLA pharmaceuticals contract vehicle and supports the Agency's mission to provide critical medicines and medical supplies to...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Novolog 100 Unit/mL FlexPen 3mL insulin pens. This non-set-aside, competitively awarded contract has a ceiling value of $1,794.04 with a firm fixed price structure and an ultimate completion date of December 22, 2025. The delivery order will be fulfilled at AmerisourceBergen's Conshohocken facility and...
- The Defense Logistics Agency awarded a $637.30 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561909632 Novolog 100 unit/ml Flexpen 3ml insulin injector pens. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and tasks Amerisourcebergen to deliver the insulin pens to a location in Conshohocken, Pennsylvania by August 24, 2023 in support of the DLA's medical logistics programs. No subcontractors or set aside designations...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB23FWS79Delivery Order
The Defense Logistics Agency awarded a $34,040 delivery order to Amerisourcebergen Drug Corporation for 4561696823 Novolog 100 unit/ml Flexpen 3ml insulin delivery devices. As a prime contractor for DLA's pharmaceutical supply chain programs, Amerisourcebergen will deliver the insulin pens from its facility in Conshohocken, Pennsylvania to an unspecified customer by August 4, 2023 under firm fixed pricing. The delivery order was issued against an existing DLA pharmaceutical supply vehicle to support the Agency's medical logistics operations, though no major subcontractors or set aside designations were identified in the award information provided.
Generated 12/24/23, 8:11 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34 | 8/3/23 |